iCardiac Technologies, a market and scientific leader in the conduct of cardiac safety assessments, announced today that it has launched the industry’s first full risk-sharing program for Thorough QT studies.

See more here:
iCardiac launches industry-first full risk-sharing program for cardiac safety studies